Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Photodynamic therapy is an accepted but underappreciated treatment for solid cancers Invion has announced promising results from its first-in-human trial, for prostate cancer The company ... drugs ...

Scientists are unsure as to what causes prostate cancer, but age, obesity and a lack of exercise are known risks. Anyone with any concerns can speak to Prostate Cancer UK's specialist nurses on ...

Moderna and MSD have initiated a Phase III clinical study to evaluate mRNA-4157 (V940), an investigational individualised neoantigen therapy, in combination with Keytruda to treat non-small cell ...

Prostate cancer ... So how does it work? And how does it compare to existing therapies? Stereotactic radiotherapy uses high doses of radiation to target and kill cancer cells.

Prostate cancer is the second leading cause of cancer deaths among men in the U.S., but ... This phenomenon – treatment without strong clinical indication, based on anxiety – definitely does happen ...

Many other health problems can also cause ... of cancer treatments and prostate cancer surgery choices from the National Cancer Institute. Anything that increases your chance of getting a disease is ...

While red meat—which includes veal, pork, lamb, beef, or goat meat—does have health benefits, some studies have shown that consuming red meat may increase your risk of certain cancers such as colon, ...